The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of the phase IB part of the LOC-R01 trial, a non-comparative randomized phase IB/II study of escalating doses of lenalidomide and ibrutinib in association with R-MPV for patients with a newly diagnosed primary central nervous system lymphoma (PCNSL).
 
Marion Alcantara
Honoraria - Janssen
Research Funding - Mnemo Therapeutics
 
Marion Chevrier
No Relationships to Disclose
 
Fabrice Jardin
Honoraria - Abbvie/Genentech; Abbvie/Genentech; Celgene; Janssen; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Anna Schmitt
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi
 
Caroline Houillier
No Relationships to Disclose
 
Lucie Oberic
Honoraria - Bristol-Myers Squibb; Janssen; Kite, a Gilead Company
Consulting or Advisory Role - Incyte; Kite, a Gilead Company; Roche
 
Olivier L. Chinot
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Roche
 
Franck Morschhauser
Honoraria - Chugai/Roche; Eisai; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; epizyme; Genmab; Gilead Sciences; Novartis; Roche/Genentech; SERVIER
 
Frederic Peyrade
Honoraria - MSD Oncology
 
Roch Houot
Honoraria - Incyte; Janssen; Kite/Gilead; MSD; Novartis; Roche; Takeda
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb/Celgene; Incyte; Kite/Gilead; Miltenyi Biomedicine; Novartis
 
Christine Foulon
No Relationships to Disclose
 
Estelle Chauvin
No Relationships to Disclose
 
Herve Ghesquieres
Honoraria - Gilead Sciences; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Roche
Travel, Accommodations, Expenses - Abbvie
 
Carole Soussain
Research Funding - HANGZHOU HEZHENG PHARMACEUTICAL (Inst)
Travel, Accommodations, Expenses - GOSSAMER BIO